A Pilot Study of MicroRNAs Expression Profile in Serum and HBsAg Particles: Predictors of Therapeutic Vaccine Efficacy in Chronic Hepatitis B Patients

Medicine
Weixia WangZheng-Hong Yuan

Abstract

Chronic hepatitis B (CHB) remains a global health problem. Therapeutic vaccination has been successfully employed to treat a subpopulation of CHB patients. Personalized treatment can not only improve therapeutic efficacy, but also decrease the cost of medical care. Since microRNAs (miRNAs) are highly conserved and are involved in many cellular processes, exploring their expression profiles in CHB patients in association with responsiveness to therapeutic vaccination may be an approach for personalized treatment. In this study, we examined the kinetic expression profiles of 13 miRNAs in sera and serum-derived hepatitis surface antigen (HBsAg) particles in 10 CHB patients including 5 responders and 5 nonresponders selected from a large cohort of 136 patients enroled in a phase III clinical trial using antigen-antibody immunogenic complex based therapeutic vaccine (YIC). Eight miRNAs were detected in both sera and HBsAg particles. Among them, the levels of serum miRNAs and serum-derived HBsAg-carried miRNAs (let-7f, miR-22, miR-30a, and miR-122) were significantly lower in the responders group compared to those in the nonresponders group at baseline and throughout the course of treatment. The lower baseline levels of serum miRNAs ...Continue Reading

References

Sep 17, 2004·Nature·Victor Ambros
Mar 23, 2005·Vaccine·Dao-Zhen XuYu-Mei Wen
Oct 3, 2006·Developmental Cell·Wigard P Kloosterman, Ronald H A Plasterk
Oct 31, 2006·Trends in Molecular Medicine·Ramiro GarzonCarlo M Croce
Feb 14, 2008·Nature Reviews. Molecular Cell Biology·Giovanni Stefani, Frank J Slack
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Sep 6, 2008·PloS One·Shlomit GiladAyelet Chajut
Mar 20, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wei-Chih TsaiAnn-Ping Tsou
Sep 10, 2009·Gastroenterology·Fabien Zoulim, Stephen Locarnini
Aug 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vincent RijckborstHarry L A Janssen
Jan 18, 2011·Journal of Hepatology·Marie-Louise MichelMaryline Mancini-Bourgine
Oct 12, 2011·Annals of Hematology·Cheng FangJian-Yong Li
Nov 23, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Saifeng WangSongdong Meng
Apr 4, 2012·PloS One·Luisa NovellinoMaurizia R Brunetto
Jul 9, 2013·Nature Immunology·Jianhua LiZhenghong Yuan
Feb 21, 2014·F1000Research·Claire L Le GuenNicholas J Hand
May 31, 2014·World Journal of Gastroenterology : WJG·Weiqi TanTheresa M C Tan
Sep 19, 2014·World Journal of Gastroenterology : WJG·Han-Shao Liu, Hua-Sheng Xiao
Oct 7, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Dayeon YuYong Chan Lee
Oct 14, 2014·Journal of Hepatology·Simonetta BandieraMirjam B Zeisel

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
PCRs

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.